Advanced Flower Capital Inc. (AFCG) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's earnings call reveals several negative indicators: realized losses impacting earnings, a significant CECL reserve indicating expected credit losses, and a negative distributable earnings per share for the quarter. Despite an expanded investment mandate and a growing pipeline, there is uncertainty about sustaining loan originations and reluctance to invest in cannabis due to regulatory issues. The lack of guidance on certain questions during the Q&A further adds to uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
Key Financial Performance
Distributable Earnings (Quarter) Negative $0.12 per basic weighted average share, primarily due to realized losses from two underperforming credits recognized during the year.
Distributable Earnings (Full Year) Positive $0.39 per basic weighted average share, primarily due to realized losses from two underperforming credits recognized during the year.
Net Interest Income (Quarter) $5.2 million.
Net Interest Income (Full Year) $24.6 million.
GAAP Net Income (Quarter) $900,000 or $0.04 per basic weighted average common share.
GAAP Net Loss (Full Year) $20.7 million or $0.95 per basic weighted average common share.
Principal Outstanding (End of Q4 2025) $317.4 million spread across 15 loans.
Principal Outstanding (As of February 25, 2026) $366.4 million spread across 15 loans.
Unsecured Bonds Repurchased (Quarter) $13 million.
Unsecured Bonds Remaining $77 million with maturity in May 2027.
CECL Reserve (End of 2025) $46.1 million or approximately 18.2% of loans at carrying value.
Unrealized Loss (End of 2025) $27.7 million for loans held at fair value.
Total Assets (End of 2025) $275.6 million.
Total Shareholder Equity (End of 2025) $175.6 million.
Book Value Per Share (End of 2025) $7.46.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Commitments in 2025: AFC originated $53 million of new commitments during fiscal year 2025.
Post-Year-End Commitments: Closed on $89.7 million of new commitments in the lower middle market after year-end.
BDC Conversion Impact: Expanded investment flexibility to pursue opportunities beyond real estate-backed loans, including operating businesses.
New Loans in Q1 2026: Closed a $60 million senior secured credit facility for STAT and Moresby Group acquisition and a $30 million commitment for a healthcare benefits platform.
Lower Middle Market Focus: Active pipeline of over $1.4 billion in deals, focusing on loans to cash-flowing borrowers with $5 million to $50 million EBITDA.
Portfolio Management: Received $117 million in paydowns from performing and underperforming credits in 2025, including $1.8 million in prepayment and exit fees.
Nonaccrual Loans: Three loans on nonaccrual; efforts ongoing to receive paydowns and redeploy capital into performing credits.
Private Company Liquidations: Progress in liquidating assets of private companies A and K, with expected distributions continuing into 2026.
BDC Conversion: Completed conversion from a REIT to a BDC as of January 1, 2026, to enhance long-term shareholder value.
Focus on Recovery and Growth: Actively managing underperforming loans to preserve shareholder capital and maximize recovery value.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Underperforming Credits: AFC faced challenges with underperforming credits, leading to realized losses and negative distributable earnings for the quarter. The company is actively managing these credits to preserve capital and maximize recovery value.
Nonaccrual Loans: Three loans are currently on nonaccrual status, impacting earnings. AFC is focused on receiving paydowns and redeploying capital into performing credits.
Private Company A Liquidation: The liquidation process for Private Company A has been slow, with delays in court-approved distributions. This has caused frustration and uncertainty in recovery timelines.
Private Company K Asset Sales: The sale of assets from Private Company K is pending regulatory approval, delaying the completion of collateral liquidation and recovery.
Justice Grown Legal Issues: Ongoing legal disputes and appeals related to Justice Grown are creating uncertainty and may affect the maturity loan due in May 2026.
Realized Losses: Realized losses from underperforming credits in 2025 have impacted earnings and may continue to affect future dividends and financial performance.
Unsecured Bonds: $77 million of unsecured bonds remain outstanding, with maturity in May 2027. The company is exploring refinancing options, but this represents a financial obligation.
CECL Reserve: The CECL reserve of $46.1 million, representing 18.2% of loans at carrying value, indicates a significant level of expected credit losses.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Future dividends: Future dividends may receive similar treatment as 2025 distributions, which were tax-free, if AFC recognizes additional losses in 2026. The Board of Directors has declared a first quarter dividend of $0.05 per share, to be paid on April 15, 2026, to shareholders of record on March 31, 2026.
Portfolio management and earnings potential: AFC is focused on receiving paydowns on nonaccrual loans and redeploying that capital into performing credits, which is expected to contribute to current income and unlock future earnings potential.
Liquidation process for private company A: AFC expects distributions from the liquidation process to continue flowing in over the course of 2026 as regulatory approvals and other milestones are met.
Sale of collateral for private company K: The sale of all collateral for private company K is expected to be completed sometime in 2026, pending regulatory approval.
Justice Grown loan maturity: The Justice Grown loan matures on May 1, 2026, and AFC expects a ruling on the appeal of the preliminary injunction in the coming months.
Expanded investment strategy: Since converting to a BDC, AFC has expanded its investment strategy to include a broader universe of operating businesses. The active pipeline remains strong with over $1.4 billion in deals as of today, focusing on loans to cash-flowing borrowers with $5 million to $50 million of EBITDA.
New loans in Q1 2026: AFC closed a $60 million senior secured credit facility to support the combination of STAT and the Moresby Group and committed $30 million to a $60 million senior secured term loan to support the acquisition and growth of a leading healthcare benefits platform.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
2025 Dividends: Characterized as a return of capital, making the 2025 distributions to shareholders tax-free. Future dividends may receive similar treatment if AFC recognizes additional losses in 2026.
First Quarter 2026 Dividend: The Board of Directors declared a first quarter dividend of $0.05 per share, to be paid on April 15, 2026, to shareholders of record on March 31, 2026.
Unsecured Bonds Repurchase: During the quarter, AFC repurchased $13 million of its unsecured bonds. Currently, $77 million of unsecured bonds remain outstanding with maturity in May 2027.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What led to the significant increase in the active pipeline to $1.4 billion from $400 million last quarter?
A:The increase is primarily due to the company's conversion from a REIT to a BDC, which expanded the investable universe beyond cannabis and allowed investments in cash flow loans not fully covered by real estate.
Q:Can you provide a split between the cannabis and non-cannabis pipeline and the expected yields for the non-cannabis portfolio?
A:The company does not break out the pipeline by industry, including cannabis. For yields, the last two loans in the lower middle market had yields to maturity of 14% and 19%, as shown on Page 14 of the deck.
Q:What is the recovery status for private company A and private company K, and any updates on Justice Grown?
A:For private company A, $6.8 million was distributed in 2025, and $6.4 million is pending distribution. Additional assets will be monetized over time. For private company K, two dispensaries are under APA and awaiting regulatory approval, while the third dispensary sale is expected in 2026. No further comments were provided on Justice Grown beyond the loan being due in May.
Q:Can the $100 million per quarter pace of loan originations be sustained for the rest of the year, and how will it be funded?
A:The $100 million per quarter pace is not currently sustainable with existing cash and credit facilities. Proceeds from nonaccrual loans could help, but they are difficult to predict. The company is focused on deploying capital into attractive lower middle market loans.
Q:Will the company make new loans in cannabis this year given the regulatory landscape?
A:The bar for new cannabis loans is very high due to limited regulatory progress, lack of equity capital, and tax liabilities in the industry. The company remains cautious about deploying fresh capital into cannabis.
Q:Does the Blue Owl Capital situation affect the company’s performance or investor sentiment?
A:The company does not comment on other companies' situations. It focuses on its own credit performance and portfolio, feeling confident about its middle market loans.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the split between cannabis and non-cannabis pipelines, as well as further updates on Justice Grown beyond the loan's due date in May. They also refrained from commenting on the Blue Owl Capital situation, stating they would not speak on other companies' books.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AFC President
AFC acquisition
AFC commitment
AFC filing
AFC portfolio
AFC release
AFC term
Amazon ecosystem
BDC conversion
BDC loan
BDC overview
BDC universe
CIO Co
Cambridge Capital
Capital Instructions
Capital STAT
Fortune
Moresby
agreement
appeal
beginning today
capital credit
closing
conversion BDC
credit potential
deal
detail
distribution proceeds
estate
expansion
loan capital
portfolio effort
recovery
specialist
today AFC
today paydowns
AFCG Transcript
Advanced Flower Capital Inc. (AFCG) Q4 2025 Earnings Call Transcript
Unknown3-4
The company's earnings call reveals several negative indicators: realized losses impacting earnings, a significant CECL reserve indicating expected credit losses, and a negative distributable earnings per share for the quarter. Despite an expanded investment mandate and a growing pipeline, there is uncertainty about sustaining loan originations and reluctance to invest in cannabis due to regulatory issues. The lack of guidance on certain questions during the Q&A further adds to uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
Advanced Flower Capital Inc. (AFCG) Q3 2025 Earnings Call Transcript
Unknown11-12
The earnings call reveals a mix of financial challenges, such as GAAP net loss and decreased distributable earnings, alongside strategic shifts like the BDC conversion. However, the lack of clear guidance on dividends and deployment, coupled with management's evasive responses, suggests uncertainty. The potential positive impact of diversification and capital returns is overshadowed by immediate financial underperformance and unclear future plans, leading to a negative sentiment.
Advanced Flower Capital Inc. (AFCG) Q2 2025 Earnings Call Transcript
Unknown8-14
The earnings call reveals several negative factors: a GAAP net loss, increased CECL reserves, unrealized losses, and no year-over-year improvements in key financial metrics. The Q&A section highlights uncertainties regarding the BDC conversion's impact on investment opportunities and credit facilities, coupled with a lack of clarity on future portfolio composition. Despite some optimism about rescheduling cannabis, the overall sentiment is cautious. Given these factors, the stock is likely to experience a negative reaction, with a potential decline in the -2% to -8% range.
AFC Gamma, Inc. (NASDAQ:AFCG) Q1 2025 Earnings Call Transcript
Unknown5-15
The earnings call reveals several negative factors: an EPS miss, supply-demand imbalance in the cannabis sector, legal proceedings, and underperformance of legacy loans. The Q&A section shows management's reluctance to provide guidance on key financial metrics, which further adds to uncertainty. Despite a high portfolio yield, the lack of a share repurchase program and ongoing legal issues weigh negatively. The absence of a strong partnership or positive guidance adjustment limits potential upside. Overall, these factors suggest a negative outlook for the stock price in the short term.
AFCG Slides
AFCG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
